Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right

Published:2016-07 Issue:7 Volume:42 Page:994-998
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Francis A.^ORCID,Bartlett J.,Rea D.,Pinder S.E.,Stein R.C.,Stobart H.,Purdie C.A.^ORCID,Rakha E.,Thompson A.,Shaaban A.M.

Funder

National Institute for Health Research

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference28 articles.

1. Best practice diagnostic guidelines for patients presenting with breast symptoms;Association of Breast Surgeons,2010

2. NHS Cancer Screening Programmes and the Royal College of Pathologists;Pathol Report Breast Dis,2005

3. Updated UK recommendations for HER2 assessment in breast cancer;Rakha;J Clin Pathol,2015

4. Early and locally advanced breast cancer: diagnosis and treatment;NICE guidelines [CG80],2009

5. HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice;Shaaban;J Clin Pathol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UK recommendations for HER2 assessment in breast cancer: an update;Journal of Clinical Pathology;2022-12-23

2. Multidisciplinary Meeting;Breast Cancer Essentials;2021

3. Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patients;The Breast;2020-08

4. Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams;British Journal of Surgery;2019-11-05

5. The importance of histological assessment after neoadjuvant therapy and the need for standardisation;Clinical Radiology;2018-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3